Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astera Labs (ALAB) EBITDA (2023 - 2026)

Astera Labs has reported EBITDA over the past 3 years, most recently at $45.2 million for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 118.24% year-over-year to $45.2 million, compared with a TTM value of $223.0 million through Dec 2025, up 367.88%, and an annual FY2025 reading of $223.0 million, up 367.88% over the prior year.
  • EBITDA came in at $45.2 million for Q4 2025, down from $92.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $92.3 million in Q3 2025 to a low of -$93.3 million in Q1 2024.
  • Median EBITDA over the past 3 years was $6.0 million (2023), compared with a mean of $9.5 million.
  • The sharpest move saw EBITDA plummeted 441.07% in 2024, then soared 3384.85% in 2025.
  • Over 3 years, EBITDA stood at $14.9 million in 2023, then soared by 39.0% to $20.7 million in 2024, then soared by 118.24% to $45.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBITDA are $45.2 million (Q4 2025), $92.3 million (Q3 2025), and $52.1 million (Q2 2025).